MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
The New England Journal of Medicine Downloaded from nejm.org on November 8, 2012. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 8, 2012. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 8, 2012. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 8, 2012. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 8, 2012. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
The New England Journal of Medicine Downloaded from nejm.org on November 8, 2012. For personal use only. No other uses without permission. Copyright © 1990 Massachusetts Medical Society. All rights reserved.
Suggest Documents
Cathepsin D in breast cancer.
Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer.
[Cathepsin D in primary breast cancer in correlation with various prognostic factors].
Relation of cathepsin D level to the estrogen receptor in human breast cancer.
Expression of cathepsin D in head and neck cancer.
Cathepsin D in breast cancer: a tissue marker associated with metastasis.
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.
Repression of cathepsin E expression increases the risk of mammary carcinogenesis and links to poor prognosis in breast cancer.
Age and prognosis in breast cancer.
Clinical and Biological Significance of Cathepsin D Levels in Breast Cancer Cytosol in Women Over 70 years.
Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Crystallization of cathepsin D.
Alteration of cathepsin D trafficking induced by hypoxia and extracellular acidification in MCF-7 breast cancer cells.
Immunostaining of cathepsin D in breast cancer: quantification by computerised image analysis and correlation with cytosolic assay.
Cathepsin D and epidermal growth factor in human breast cyst fluid.
CORRELATIONSHIP OF CATHEPSIN D AND TOPOISOMERASE II ALPHA WITH NUCLEAR GRADING IN BREAST CANCERS.
Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.
Cathepsin D of rat spleen. Affinity purification and properties of two types of cathepsin D.
The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer.
Quantification and molecular analysis of cathepsin D in breast cyst fluids.
Prolonged Nightly Fasting and Breast Cancer Prognosis.
Diabetes, diabetes treatment and breast cancer prognosis.
A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.
Autoimmune Thyroid Disease and Breast Cancer Prognosis.
Cathepsin D and prognosis in breast cancer.
We investigated the possibility that cathepsin D, an estrogen-induced lysosomal protease, might have value as a prognostic factor in breast cancer by ...
1MB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Cathepsin D in breast cancer.
Increased plasma cathepsin D concentration in hepatic carcinoma and cirrhosis but not in breast cancer.
[Cathepsin D in primary breast cancer in correlation with various prognostic factors].
Relation of cathepsin D level to the estrogen receptor in human breast cancer.
Expression of cathepsin D in head and neck cancer.
Cathepsin D in breast cancer: a tissue marker associated with metastasis.
p53, cathepsin D, Bcl-2 are joint prognostic indicators of breast cancer metastatic spreading.
Repression of cathepsin E expression increases the risk of mammary carcinogenesis and links to poor prognosis in breast cancer.
Age and prognosis in breast cancer.
Clinical and Biological Significance of Cathepsin D Levels in Breast Cancer Cytosol in Women Over 70 years.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms